Endometriosis associated diseases, endometriosis and cancer: what is in common?

Close metadata

The review presents a comparative characteristic of endometriosis and cancer with respect to such parameters as the classifications of ovarian tumors, risk factors, histological picture including specific signs of atypical endometriosis, pathogenetic aspects. Assumes most of the chronic diseases found in the population and endometriosis. The association of most chronic diseases occurring in the population and endometriosis is considered. Clinical cases of rare forms of endometriosis-associated cancer in various localization are presented. Potential factors of malignant transformation of endometriosis are described. Taking into account some affinity of endometriosis and cancer, a possibility of repositioning the drugs that undergo studies for treatment of oncological diseases is also discussed.

Keywords:

clear cell carcinoma

endometriosis-associated ovarian tumors

endometrioid ovarian cancer

atypical endometriosis

cell line clonality

Authors:

Adamyan L.V.

Moscow State Medical and Dental University named after A.I. Evdokimov

SPIN RSCI: 9836-2713
Scopus AuthorID: 7006372422
ResearcherID: Q-1722-2018
ORCID: 0000-0002-3253-4512

Protasova A.E.

Saint Petersburg State University;
I.I. Mechnikov North-Western State Medical University of the Ministry of Health of Russia;
OOO «AVA-PETER»;
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology;
V.A. Almazov National Medical Research Center of the Ministry of Health of Russia

ORCID: 0000-0001-7930-8048

Asaturova A.V.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

ORCID: 0000-0001-8739-5209

Raskin G.A.

Dr. Berezin Medical Institute;
Saint-Petersburg State University

ORCID: 0000-0002-7522-6552

Received:

22.02.2022

Accepted:

01.03.2022

List of references:

Mezhlumova NA, Bobrov MYu, Adamyan LV. Biomarkers of endometriosis: problems and possibilities of early diagnosis of relapses of the disease (literature review). Problemy reprodukcii. 2018;24(6):139-148. (In Russ.). https://doi.org/10.17116/repro201824061139
Adamyan LV, Aznaurova YaB. Endometriosis and cancer: comparative characteristics and new prospects for treatment and prevention. Voprosy ginekologii, akusherstva i perinatologii. 2020;19(3):95-100. (In Russ.). https://doi.org/10.20953/1726-1678-2020-3-95-100
Koninckx PR, Ussia A, Adamyan L, Tahlak M, Keckstein J, Wattiez A, Martin DC. The epidemiology of endometriosis is poorly known as the pathophysiology and diagnosis are unclear. Best Practice and Research. Clinical Obstetrics and Gynaecology. 2021;71:14-26. https://doi.org/10.1016/j.bpobgyn.2020.08.005
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA: a Cancer Journal for Clinicians. 2022;72(1):7-33. https://doi.org/10.3322/caac.21708
Stilidi IS, Gevorkyan TG, Shpak AG. Improvement of indicators of the federal project «Fight against oncological diseases». Vestnik Roszdravnadzora. 2021;1:46-53. (In Russ.).
Murashko MA. Mikhail Murashko: «Following the results of the implementation of the national project «healthcare» in 2020, it was possible to achieve the most important socially significant results». Vestnik Roszdravnadzora. 2021;1:6-12. (In Russ.).
Kawahara N, Miyake R, Yamanaka S, Kobayashi H. A Novel Predictive Tool for Discriminating Endometriosis Associated Ovarian Cancer from Ovarian Endometrioma: The R2 Predictive Index. Cancers. 2021;13(15):3829. https://doi.org/10.3390/cancers13153829
Bian LH, Wang M, Gong J, Liu HH, Wang N, Wen N, Fan WS, Xu BX, Wang MY, Ye MX, Meng YG. Comparison of integrated PET/MRI with PET/CT in evaluation of endometrial cancer: a retrospective analysis of 81 cases. Peer J. 2019;7:e7081. https://doi.org/10.7717/peerj.7081
Lorusso F, Scioscia M, Rubini D, Stabile Ianora AA, Scardigno D, Leuci C, De Ceglie M, Sardaro A, Lucarelli N, Scardapane A. Magnetic resonance imaging for deep infiltrating endometriosis: current concepts, imaging technique and key findings. Insights Into Imaging. 2021;12(1):105. https://doi.org/10.1186/s13244-021-01054-x
Prašnikar E, Knez J, Kovačič B, Kunej T. Molecular signature of eutopic endometrium in endometriosis based on the multi-omics integrative synthesis. Journal of Assisted Reproduction and Genetics. 2020;37(7):1593-1611. https://doi.org/10.1007/s10815-020-01833-3
Tian Z, Chang XH, Zhao Y, Zhu HL. Current biomarkers for the detection of endometriosis. Chinese Medical Journal. 2020;133(19): 2346-2352. https://doi.org/10.1097/CM9.0000000000001063
Shukla KK, Sankanagoudar S, Sanganeria BS, Pareek P, Ram J, Misra S, Sharma P. Recent Advances in Molecular Diagnostic Approaches for Cancer. In book Molecular Diagnostics in Cancer Patients. 2019:1-9. https://doi.org/10.1007/978-981-13-5877-7_1
Stopiglia RM, Ferreira U, Faundes DG, Petta CA. Cystoscopy-assisted laparoscopy for bladder endometriosis: modified light-to-light technique for bladder preservation. International Braz J Urol. 2017; 43(1):87-94. https://doi.org/10.1590/S1677-5538.IBJU.2014.0362
Stephansson O, Falconer H, Ludvigsson JF. Risk of endometriosis in 11,000 women with celiac disease. Human Reproduction. 2011; 26(10):2896-2901. https://doi.org/10.1093/humrep/der263
Jess T, Frisch M, Jørgensen KT, Pedersen BV, Nielsen NM. Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study. Gut. 2012;61(9):1279-1283. https://doi.org/10.1136/gutjnl-2011-301095
Nielsen NM, Jørgensen KT, Pedersen BV, Rostgaard K, Frisch M. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome. Human Reproduction. 2011;26(6):1555-1559. https://doi.org/10.1093/humrep/der105
Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Human Reproduction. 2002;17(10):2715-2724. https://doi.org/10.1093/humrep/17.10.2715
Shafrir AL, Palmor MC, Fourquet J, DiVasta AD, Farland LV, Vitonis AF, Harris HR, Laufer MR, Cramer DW, Terry KL, Missmer SA. Co-occurrence of immune-mediated conditions and endometriosis among adolescents and adult women. American Journal of Reproductive Immunology. 2021;86(1):e13404. https://doi.org/10.1111/aji.13404
O’Malley J, Iacovou M, Holdsworth-Carson SJ. Evidence for an Association Between Endometriosis and Allergic and Non-allergic Food Hypersensitivity Is Lacking. Frontiers in Reproductive Health. 2021;3:78. https://doi.org/10.3389/frph.2021.726598
Peng YH, Su SY, Liao WC, Huang CW, Hsu CY, Chen HJ, Wu TN, Ho WC, Wu CC. Asthma is associated with endometriosis: A retrospective population-based cohort study. Respiratory Medicine. 2017; 132:112-116. https://doi.org/10.1016/j.rmed.2017.10.004
Wei CH, Chang R, Wan YH, Hung YM, Wei JC. Endometriosis and New-Onset Coronary Artery Disease in Taiwan: A Nationwide Population-Based Study. Frontiers in Medicine. 2021;8:619664. https://doi.org/10.3389/fmed.2021.619664
Taskin O, Rikhraj K, Tan J, Sedlak T, Rowe TC, Bedaiwy MA. Link between Endometriosis, Atherosclerotic Cardiovascular Disease, and the Health of Women Midlife. Journal of Minimally Invasive Gynecology. 2019;26(5):781-784. https://doi.org/10.1016/j.jmig.2019.02.022
Mu F, Rich-Edwards J, Rimm EB, Spiegelman D, Forman JP, Missmer SA. Association between Endometriosis and Hypercholesterolemia or Hypertension. Hypertension. 2017;70(1):59-65. https://doi.org/10.1161/HYPERTENSIONAHA.117.09056
Mu F, Rich-Edwards J, Rimm EB, Spiegelman D, Missmer SA. Endometriosis and Risk of Coronary Heart Disease. Cardiovascular Quality and Outcomes. 2016;9(3):257-264. https://doi.org/10.1161/CIRCOUTCOMES.115.002224
Tan J, Taskin O, Iews M, Lee AJ, Kan A, Rowe T, Bedaiwy MA. Atherosclerotic cardiovascular disease in women with endometriosis: a systematic review of risk factors and prospects for early surveillance. Reproductive Biomedicine Online. 2019;39(6):1007-1016. https://doi.org/10.1016/j.rbmo.2019.05.021
Zhou L, Yao L, Dai L, Zhu H, Ye X, Wang S, Cheng H, Ma R, Liu H, Cui H, Chang X. Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study. Journal of Ovarian Research. 2021;14(1):63. https://doi.org/10.1186/s13048-021-00804-1
Fadare O, Parkash V. Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary. Surgical Pathology Clinics. 2019;12(2): 529-564. https://doi.org/10.1016/j.path.2019.01.009
Sun Y, Liu G. Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity? Journal of Cancer. 2021;12(22):6773-6786. https://doi.org/10.7150/jca.61107
Peiro G, Silva-Ortega S, Garcia-Espasa C, Sala-Ferichola M, Perez-Vicente S, Castellon-Molla E, Marcos-Sanmartin J. Primary peritoneal clear cell carcinoma. A case report and literature review. Gynecologic Oncology Reports. 2020;32:100551. https://doi.org/10.1016/j.gore.2020.100551
Yu HC, Lin CY, Chang WC, Shen BJ, Chang WP, Chuang CM; Task Force on Carcinogenesis of Endometrial Cancer. Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study. International Journal of Gynecological Cancer. 2015;25(3):447-452. https://doi.org/10.1097/IGC.0000000000000384
Habiba M, Pluchino N, Petignat P, Bianchi P, Brosens IA, Benagiano G. Adenomyosis and Endometrial Cancer: Literature Review. Gynecologic and Obstetric Investigation. 2018;83(4):313-328. https://doi.org/10.1159/000487320
Board TE. WHO Female genital tumors. Lyon, 2020.
Koike N, Tsunemi T, Uekuri C, Akasaka J, Ito F, Shigemitsu A, Kobayashi H. Pathogenesis and malignant transformation of adenomyosis (review). Oncology Reports. 2013;29(3):861-867. https://doi.org/10.3892/or.2012.2184
Yeh CC, Su FH, Tzeng CR, Muo CH, Wang WC. Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study. PloS One. 2018;13(3): e0194011. https://doi.org/10.1371/journal.pone.0194011
Anifantaki F, Boutas I, Kalampokas T, Kalampokas E, Sofoudis C, Salakos N. Association of endometriosis and breast cancer: mini review of the literature. Archives of Gynecology and Obstetrics. 2016; 293(1):5-10. https://doi.org/10.1007/s00404-015-3809-8
Saavalainen L, Lassus H, But A, Tiitinen A, Härkki P, Gissler M, Heikinheimo O, Pukkala E. A Nationwide Cohort Study on the risk of non-gynecological cancers in women with surgically verified endometriosis. International Journal of Cancer. 2018;143(11):2725-2731. https://doi.org/10.1002/ijc.31721
Eoh KJ, Han M, Kim EH, Jung I, Kim YT. Markedly increased risk of malignancies in women with endometriosis. Gynecologic Oncology. 2021;161(1):291-296. https://doi.org/10.1016/j.ygyno.2021.01.019
Pontikaki A, Sifakis S, Spandidos DA. Endometriosis and breast cancer: A survey of the epidemiological studies. Oncology Letters. 2016;11(1):23-30. https://doi.org/10.3892/ol.2015.3895
Eslami B, Alipour S, Khazaei N, Sepidarkish M, Moini A. Breast Cancer Risk Factors in Patients With Endometriosis. Archives of Breast Cancer. 2018;76-80.
Missmer SA, Spiegelman D, Hankinson SE, Malspeis S, Barbieri RL, Hunter DJ. Natural hair color and the incidence of endometriosis. Fertility and Sterility. 2006;85(4):866-870. https://doi.org/10.1016/j.fertnstert.2005.12.008
Kvaskoff M, Mesrine S, Clavel-Chapelon F, Boutron-Ruault MC. Endometriosis risk in relation to naevi, freckles and skin sensitivity to sun exposure: the French E3N cohort. International Journal of Epidemiology. 2009;38(4):1143-1153. https://doi.org/10.1093/ije/dyp175
Vercellini P, Buggio L, Somigliana E, Dridi D, Marchese MA, Viganò P. ‘Behind blue eyes’†: the association between eye colour and deep infiltrating endometriosis. Human Reproduction. 2014;29(10): 2171-2175. https://doi.org/10.1093/humrep/deu169
Kvaskoff M, Mesrine S, Fournier A, Boutron-Ruault MC, Clavel-Chapelon F. Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women. Archives of Internal Medicine. 2007;167(19):2061-2065. https://doi.org/10.1001/archinte.167.19.2061
Johnatty SE, Stewart CJR, Smith D, Nguyen A, O’ Dwyer J, O’Mara TA, Webb PM, Spurdle AB. Co-existence of leiomyomas, adenomyosis and endometriosis in women with endometrial cancer. Scientific Reports. 2020;10(1):3621. https://doi.org/10.1038/s41598-020-59916-1
Maclaran K, Agarwal N, Odejinmi F. Co-existence of uterine myomas and endometriosis in women undergoing laparoscopic myomectomy: risk factors and surgical implications. Journal of Minimally Invasive Gynecology. 2014;21(6):1086-1090. https://doi.org/10.1016/j.jmig.2014.05.013
Tetikkurt S, Çelik E, Taş H, Cay T, Işik S, Usta AT. Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens. Molecular and Clinical Oncology. 2018;9(2):231-237. https://doi.org/10.3892/mco.2018.1660
Kumbhalwar MJ, Konda A. Prevalence of uterine lesions associated with leiomyomas and role of endometrial biopsy in management. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2020;9(7):2828-2835. https://doi.org/10.18203/2320-1770.ijrcog20202717
LE Donne M, Alibrandi A, Ciancimino L, Azzerboni A, Chiofalo B, Triolo O. Endometrial pathology in breast cancer patients: Effect of different treatments on ultrasonographic, hysteroscopic and histological findings. Oncology Letters. 2013;5(4):1305-1310. https://doi.org/10.3892/ol.2013.1156
Miki Y. New Insights into Breast and Endometrial Cancers. Cancers. 2020;12(9):2595. https://doi.org/10.3390/cancers12092595
Soliman AM, Yang H, Du EX, Kelley C, Winkel C. The direct and indirect costs associated with endometriosis: a systematic literature review. Human Reproduction. 2016;31(4):712-722. https://doi.org/10.1093/humrep/dev335
Soliman AM, Yang H, Du EX, Kelley C, Winkel C. The direct and indirect costs associated with endometriosis: a systematic literature review. Human Reproduction. 2016;31(4):712-722. https://doi.org/10.1093/humrep/dev335
Qu H, Li L, Wang TL, Seckin T, Segars J, Shih IM. Epithelial Cells in Endometriosis and Adenomyosis Upregulate STING Expression. Reproductive Sciences. 2020;27(6):1276-1284. https://doi.org/10.1007/s43032-019-00127-z
Konrad L, Dietze R, Riaz MA, Scheiner-Bobis G, Behnke J, Horné F, Hoerscher A, Reising C, Meinhold-Heerlein I. Epithelial-Mesenchymal Transition in Endometriosis-When Does It Happen? Journal of Clinical Medicine. 2020;9(6):1915. https://doi.org/10.3390/jcm9061915
Owusu-Akyaw A, Krishnamoorthy K, Goldsmith LT, Morelli SS. The role of mesenchymal-epithelial transition in endometrial function. Human Reproduction Update. 2019;25(1):114-133. https://doi.org/10.1093/humupd/dmy035
Yan D, Liu X, Xu H, Guo SW. Platelets induce endothelial-mesenchymal transition and subsequent fibrogenesis in endometriosis. Reproductive Biomedicine Online. 2020;41(3):500-517. https://doi.org/10.1016/j.rbmo.2020.03.020
Zhang Q, Duan J, Liu X, Guo SW. Platelets drive smooth muscle metaplasia and fibrogenesis in endometriosis through epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation. Molecular and Cellular Endocrinology. 2016;428:1-16. https://doi.org/10.1016/j.mce.2016.03.015
Guo SW. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology. Human Reproduction Update. 2020;26(3):423-449. https://doi.org/10.1093/humupd/dmz047
Bulun SE, Wan Y, Matei D. Epithelial Mutations in Endometriosis: Link to Ovarian Cancer. Endocrinology. 2019;160(3):626-638. https://doi.org/10.1210/en.2018-00794
Song L, Tang Z, Peng C, Yang Y, Guo C, Wang D, Guo L, Chen J, Liu C. Cell type-specific genotoxicity in estrogen-exposed ovarian and fallopian epithelium. BMC Cancer. 2020;20(1):1020. https://doi.org/10.1186/s12885-020-07524-7
Suda K, Cruz Diaz LA, Yoshihara K, Nakaoka H, Yachida N, Motoyama T, Inoue I, Enomoto T. Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis. Cancer Science. 2020;111(8):3000-3009. https://doi.org/10.1111/cas.14507
Shigetomi H, Imanaka S, Kobayashi H. Effects of iron-related compounds and bilirubin on redox homeostasis in endometriosis and its malignant transformations. Hormone Molecular Biology and Clinical Investigation. 2021;10.1515/hmbci-2021-0065. https://doi.org/10.1515/hmbci-2021-0065
Li S, Zhou Y, Huang Q, Fu X, Zhang L, Gao F, Jin Z, Wu L, Shu C, Zhang X, Xu W, Shu J. Iron overload in endometriosis peritoneal fluid induces early embryo ferroptosis mediated by HMOX1. Cell Death Discovery. 2021;7(1):355. https://doi.org/10.1038/s41420-021-00751-2
Akashi K, Nagashima Y, Tabata T, Oda H. Immunochemical analysis of iron transporters and M2 macrophages in ovarian endometrioma and clear cell adenocarcinoma. Molecular and Clinical Oncology. 2021;15(2):159. https://doi.org/10.3892/mco.2021.2321
Păvăleanu I, Lozneanu L, Balan RA, Giuşcă SE, Avădănei ER, Căruntu ID, Amălinei C. Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma. Romanian Journal of Morphology and Embryology. 2020;61(3):739-749. https://doi.org/10.47162/RJME.61.3.12
Yachida N, Yoshihara K, Suda K, Nakaoka H, Ueda H, Sugino K, Yamaguchi M, Mori Y, Yamawaki K, Tamura R, Ishiguro T, Isobe M, Motoyama T, Inoue I, Enomoto T. ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis. Scientific Reports. 2020;10(1):14260. https://doi.org/10.1038/s41598-020-71273-7
Heinze K, Nazeran TM, Lee S, Krämer P, Cairns ES, Chiu DS, Leung SCY, Kang EY, Meagher NS, Kennedy CJ, Boros J, Kommoss F, Vollert HW, Heitze F, du Bois A, Harter P, Grube M, Kraemer B, Staebler A, Kommoss FKF, Heublein S, Sinn HP, Singh N, Laslavic A, Elishaev E, Olawaiye A, Moysich K, Modugno F, Sharma R, Brand AH, Harnett PR, DeFazio A, Fortner RT, Lubinski J, Lener M, Tołoczko-Grabarek A, Cybulski C, Gronwald H, Gronwald J, Coulson P, A El-Bahrawy M, Jones ME, Schoemaker MJ, Swerdlow AJ, Gorringe KL, Campbell I, Cook L, Gayther SA, Carney ME, ShvetsovYuB, Hernandez BY, Wilkens LR, Goodman MT, Mateoiu C, Linder A, Sundfeldt K, Kelemen LE, Gentry-Maharaj A, Widschwendter M, MenonU, Bolton KL, Alsop J, Shah M, Jimenez-Linan M, Pharoah PDP, Brenton JD, Cushing-Haugen KL, Harris HR, Doherty JA, Gilks B, Ghatage P, Huntsman DG, Nelson GS, Tinker AV, Lee C-H, Goode EL, Nelson BH, Ramus SJ, Kommoss S, Talhouk A, Köbel M, Anglesio MS.Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma. medRxiv. 2021; 15:2021.09.16.21262993. https://doi.org/10.1101/2021.09.16.21262993
Bajramova NN, Protasova AE, Raskin GA, Sobivchak MS, Yarmolinskaya MI. Endometriosis-associated ovarian tumors: morphological and immunohistochemical features. Zlokachestvennye opuholi. 2019;9(2):12-19. (In Russ.). https://doi.org/10.18027/2224-5057-2019-9-2-12-19
Yang B, Wang T, Li N, Zhang W, Hu Y. The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis. Advances in Therapy. 2021;38(10):5178-5190. https://doi.org/10.1007/s12325-021-01888-3
Gemmell LC, Webster KE, Kirtley S, Vincent K, Zondervan KT, Becker CM. The management of menopause in women with a history of endometriosis: a systematic review. Human Reproduction Update. 2017;23(4):481-500. https://doi.org/10.1093/humupd/dmx011
Giannella L, Marconi C, Di Giuseppe J, Delli Carpini G, Fichera M, Grelloni C, Giuliani L, Montanari M, Insinga S, Ciavattini A. Malignant Transformation of Postmenopausal Endometriosis: A Systematic Review of the Literature. Cancers. 2021;13(16):4026. https://doi.org/10.3390/cancers13164026
Kim JH, Song SH, Kim G, Kim KA, Kim WR. The multistep process of vaginal cancer arising from deep infiltrating endometriosis: a case report. BMC Women’s Health. 2021;21(1):271. https://doi.org/10.1186/s12905-021-01410-5
Ota Y, Ota K, Takahashi T, Suzki S, Sano R, Ota I, Moriya T, Shiota M. Primary endometrioid carcinoma of the uterosacral ligament arising from deep infiltrating endometriosis 6 years after bilateral salpingo-oophorectomy due to atypical proliferative endometrioid tumor of the ovary: a rare case report. World Journal of Surgical Oncology. 2020;18(1):329. https://doi.org/10.1186/s12957-020-02105-1
Inoue N, Hirakawa T, Mitsushita J, Kitahara Y, Iwase A. Malignancies Associated with Extraovarian Endometriosis: A Literature Review. Endocrines. 2021;2(3):251-265. https://doi.org/10.3390/endocrines2030024
Wang D, Yang Q, Wang H, Liu C. Malignant transformation of hepatic endometriosis: a case report and literature review. BMC Women’s Health. 2021;21(1):249. https://doi.org/10.1186/s12905-021-01366-6
Matsuki M, Numoto I, Hamakawa T, Ishii K, Chikugo T. Primary diaphragmatic clear cell carcinoma associated with endometriosis: A case report and literature review. Gynecologic Oncology Reports. 2021;36:100733. https://doi.org/10.1016/j.gore.2021.100733
Carvalho MJ, Pais AS, Rodrigues Â, Areia AL, Figueiredo-Dias M. Providing new insights into the endometriosisassociated cancer arising in episiotomy scars. Ginekologia Polska. 2021;92(3):220-225. https://doi.org/10.5603/GP.a2020.0177
Bats AS, Zafrani Y, Pautier P, Duvillard P, Morice P. Malignant transformation of abdominal wall endometriosis to clear cell carcinoma: case report and review of the literature. Fertility and Sterility. 2008;90(4):1197.e13-16. https://doi.org/10.1016/j.fertnstert.2007.08.080
Zondervan KT, Becker CM, Missmer SA. Endometriosis. The New England Journal of Medicine. 2020;382(13):1244-1256. https://doi.org/10.1056/NEJMra1810764
Lotz L, Dittrich R, Hoffmann I, Beckmann MW. Ovarian Tissue Transplantation: Experience from Germany and Worldwide Efficacy. Clinical Medicine Insights. Reproductive Health. 2019;13: 1179558119867357. https://doi.org/10.1177/1179558119867357
Salama M, Woodruff TK. New advances in ovarian autotransplantation to restore fertility in cancer patients. Cancer Metastasis Reviews. 2015;34(4):807-822. https://doi.org/10.1007/s10555-015-9600-2
Barnett R, Banks N, Decherney AH. Endometriosis and Fertility Preservation. Clinical Obstetrics and Gynecology. 2017;60(3):517-523. https://doi.org/10.1097/GRF.0000000000000311
Lantsberg D, Fernando S, Cohen Y, Rombauts L. The Role of Fertility Preservation in Women with Endometriosis: A Systematic Review. Journal of Minimally Invasive Gynecology. 2020;27(2):362-372. https://doi.org/10.1016/j.jmig.2019.09.780
Specchia C, Baggiani A, Immediata V, Ronchetti C, Cesana A, Smeraldi A, Scaravelli G, Levi-Setti PE. Oocyte Cryopreservation in Oncological Patients: Eighteen Years’ Experience of a Tertiary Care Referral Center. Frontiers in Endocrinology. 2019;10:600. https://doi.org/10.3389/fendo.2019.00600
Courbiere B, Le Roux E, Mathieu d’Argent E, Torre A, Patrat C, Poncelet C, Montagut J, Gremeau AS, Creux H, Peigné M, Chanavaz-Lacheray I, Dirian L, Fritel X, Pouly JL, Fauconnier A, On Behalf Of The PreFerBe Expert Panel. Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process. Journal of Clinical Medicine. 2021;10(17): 3810. https://doi.org/10.3390/jcm10173810
Cobo A, Giles J, Paolelli S, Pellicer A, Remohí J, García-Velasco JA. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study. Fertility and Sterility. 2020; 113(4):836-844. https://doi.org/10.1016/j.fertnstert.2019.11.017

Close metadata